Clinical Trials Directory

Trials / Sponsors / DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company

DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Plaque Psoriasis
Phase 22024-10-25
CompletedA Study of LY4100511 (DC-853) Mass Balance and Absolute Bioavailability of LY4100511 in Healthy Male Participa
Healthy
Phase 12024-08-23
CompletedA Drug-drug Interaction Study Evaluating the Perpetrator Potential of LY4100511 (DC-853) on Midazolam, Repagli
Healthy
Phase 12024-07-16
CompletedA Study to Assess LY4100511 (DC-853) in Healthy Adult Participants
Healthy
Phase 12024-04-03
CompletedA Study to Evaluate Safety, Tolerability of LY4100511 (DC-853) in Healthy Asian and Non-Asian Participants
Healthy
Phase 12024-03-19
CompletedA Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and
Healthy Participants
Phase 12023-10-16
CompletedMass Balance and Pharmacokinetics (PK) of [14C]-DC-806 in Healthy Male Participants
Healthy Volunteers
Phase 12023-09-14
CompletedA Drug-Drug Interaction Study to Assess the Pharmacokinetics of DC-806 When Orally Administered Alone, When Co
Healthy Volunteers
Phase 12023-08-08
CompletedA Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Phase 22023-05-02
CompletedA Study to Assess S011806 (DC-806 or LY4100504) in Healthy Adult Participants and Participants With Chronic Pl
Plaque Psoriasis
Phase 12021-09-22